Podoplanin expression in odontomas: clinicopathological study and immunohistochemical analysis of 86 cases

Author(s): González-Alva P, Inoue H, Miyazaki Y, Tsuchiya H, Noguchi Y, et al.

Abstract

Podoplanin, a sialomucin-like transmembrane glycoprotein, is currently used as a specific marker for lymphatic vessels. However, podoplanin expression has also been linked to tooth development. To investigate the expression of podoplanin in odontomas, 86 tissue samples were classified and then analyzed using immunohistochemical methods. Formalin-fixed, paraffin-embedded specimens were collected and classified, followed by immunohistochemical examination. The majority of the odontomas (66.3%) were the compound type, and the remainder (33.7%) were the complex type. The patients ranged in age from 2 to 89 years (mean, 23.9 years), and 45 (52.3%) of them were male and 41 (47.7%) were female. The most common location for complex odontomas was the molar region of the mandibular bone, and that for compound odontomas was the maxillary incisor region. Immunohistochemistry revealed that developing and mature odontoblasts, Tomes' fibers, and pulp cells near podoplanin-positive odontoblasts were positive for podoplanin. In addition, podoplanin positivity was evident in secretory ameloblasts, but not in mature ameloblasts. The pattern of podoplanin expression in odontomas corresponds to development of the tooth germ, and appears to be influenced by the stage of differentiation of the lesion, suggesting that the protein may participate in the process of differentiation.

Similar Articles

Overexpression of podoplanin in oral cancer and its association with poor clinical outcome

Author(s): Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, et al.

Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas

Author(s): Rodrigo JP, García-Carracedo D, González MV, Mancebo G, Fresno MF, et al.

The role of podoplanin in tumor progression and metastasis

Author(s): Raica M, Cimpean AM, Ribatti D

Genetics/epigenetics of oral premalignancy: current status and future research

Author(s): Lingen MW, Pinto A, Mendes RA, Franchini R, Czerninski R, et al.

Overexpression of podoplanin in oral cancer and its association with poor clinical outcome

Author(s): Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, et al.

The significance of podoplanin expression in human inflamed gingiva

Author(s): Miyazaki Y, Okamoto E, González-Alva P, Hayashi J, Ishige T, et al.

Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy

Author(s): Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, et al.

Podoplanin expression in oral leukoplakia: tumorigenic role

Author(s): De Vicente JC, Rodrigo JP, Rodriguez-Santamarta T, Lequerica-Fernández P, Allonca E, et al.

Overexpression of podoplanin in oral cancer and its association with poor clinical outcome

Author(s): Yuan P, Temam S, El-Naggar A, Zhou X, Liu DD, et al.

The potential role of podoplanin in tumour invasion

Author(s): Wicki A, Christofori G

The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis

Author(s): Kunita A, Kashima TG, Morishita Y, Fukayama M, Kato Y, et al.

Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition

Author(s): Martín-Villar E, Megías D, Castel S, Yurrita MM, Vilaró S, et al.

Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431

Author(s): Atsumi N, Ishii G, Kojima M, Sanada M, Fujii S, et al.

The potential role of podoplanin in tumour invasion

Author(s): Wicki A, Christofori G